Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.

Item

http://www.wikidata.org/entity/Q38517691

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Monitoring ankylosing spondyli ...... ediction of clinical outcomes.

@en

type

Item

label

Monitoring ankylosing spondyli ...... ediction of clinical outcomes.

@en

prefLabel

Monitoring ankylosing spondyli ...... ediction of clinical outcomes.

@en

P1476

Monitoring ankylosing spondyli ...... ediction of clinical outcomes.

@en

P2093

Andrea Regel

http://www.w3.org/2001/XMLSchema#string

Frank Heldmann

http://www.w3.org/2001/XMLSchema#string

Juergen Braun

http://www.w3.org/2001/XMLSchema#string

Michael Sarholz

http://www.w3.org/2001/XMLSchema#string

Uta Kiltz

http://www.w3.org/2001/XMLSchema#string

Xenofon Baraliakos

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination Survey.

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials.

Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

P304

935-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2015.1052795

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26048334

http://www.w3.org/2001/XMLSchema#string